Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cell adhesion molecule binding	OBSCN DAB2 EXOC3 SVEP1 CNTN6 MPRIP CCN5 NEO1 FBN1 NRXN1 NRXN2 PTPRM PVR GCN1 CCN3 NOP56 EDIL3 TENM3 GIGYF2 CTNNA2 BCAM ARHGAP18	2.97e-06	599	237	22	GO:0050839
GeneOntologyMolecularFunction	calcium ion binding	EFCAB5 SVEP1 C2CD5 STAB1 CAPN8 FAT2 FBN1 FBN2 HMCN2 NRXN1 USP32 NID1 CABP2 PLCD4 CUBN EDIL3 RAB44 USP6 MEGF6 HMCN1 GUCA1A EGFLAM AGRN FBN3	1.06e-05	749	237	24	GO:0005509
GeneOntologyMolecularFunction	ribose phosphate diphosphokinase activity	PRPS2 PRPS1L1 PRPS1	1.62e-05	5	237	3	GO:0004749
GeneOntologyMolecularFunction	diphosphotransferase activity	PRPS2 PRPS1L1 PRPS1	3.22e-05	6	237	3	GO:0016778
GeneOntologyMolecularFunction	extracellular matrix structural constituent	FBN1 FBN2 HMCN2 NID1 MXRA5 EDIL3 COL18A1 HMCN1 AGRN FBN3	8.66e-05	188	237	10	GO:0005201
GeneOntologyMolecularFunction	cyclin-dependent protein serine/threonine kinase activity	CDK8 CDK19 CDK11B CDK6	4.16e-04	30	237	4	GO:0004693
GeneOntologyMolecularFunction	cyclin-dependent protein kinase activity	CDK8 CDK19 CDK11B CDK6	4.16e-04	30	237	4	GO:0097472
GeneOntologyMolecularFunction	laminin binding	NID1 FKRP BCAM AGRN	6.78e-04	34	237	4	GO:0043236
GeneOntologyMolecularFunction	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides	CD101 CAD DPYSL4	8.25e-04	16	237	3	GO:0016812
GeneOntologyMolecularFunction	N-acetylmuramoyl-L-alanine amidase activity	PGLYRP3 PGLYRP1	8.29e-04	4	237	2	GO:0008745
GeneOntologyMolecularFunction	bisphosphoglycerate mutase activity	PGAM1 PGAM4	8.29e-04	4	237	2	GO:0004082
GeneOntologyMolecularFunction	2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity	PGAM1 PGAM4	8.29e-04	4	237	2	GO:0046538
GeneOntologyMolecularFunction	phosphoglycerate mutase activity	PGAM1 PGAM4	8.29e-04	4	237	2	GO:0004619
GeneOntologyCellularComponent	ribose phosphate diphosphokinase complex	PRPS2 PRPS1L1 PRPS1	1.45e-05	5	239	3	GO:0002189
GeneOntologyCellularComponent	myosin filament	MYBPH OBSCN TRIM32 MYBPC2	1.75e-04	25	239	4	GO:0032982
GeneOntologyCellularComponent	RAVE complex	DMXL1 DMXL2	3.88e-04	3	239	2	GO:0043291
GeneOntologyCellularComponent	microfibril	FBN1 FBN2 FBN3	3.88e-04	13	239	3	GO:0001527
GeneOntologyCellularComponent	basement membrane	FBN1 HMCN2 NID1 COL18A1 HMCN1 EGFLAM AGRN	5.14e-04	122	239	7	GO:0005604
GeneOntologyCellularComponent	extracellular matrix	SVEP1 CCN5 FBN1 FBN2 FCGBP HMCN2 NID1 CCN3 MXRA5 ADAMTSL3 EDIL3 COL18A1 MEGF6 HMCN1 EGFLAM BCAM AGRN FBN3	5.77e-04	656	239	18	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	SVEP1 CCN5 FBN1 FBN2 FCGBP HMCN2 NID1 CCN3 MXRA5 ADAMTSL3 EDIL3 COL18A1 MEGF6 HMCN1 EGFLAM BCAM AGRN FBN3	5.97e-04	658	239	18	GO:0030312
GeneOntologyCellularComponent	axon	KIF21B ACADM EXOC3 VPS16 CHRM2 CNTN6 NEO1 HMCN2 NRXN1 COBL CCN3 CAD ATG7 NRTN FZD3 SMURF1 GRIA1 ARHGAP4 TENM3 CPEB4 CTNNA2 AGRN	6.04e-04	891	239	22	GO:0030424
GeneOntologyCellularComponent	striated muscle myosin thick filament	OBSCN TRIM32	7.69e-04	4	239	2	GO:0005863
GeneOntologyCellularComponent	I-kappaB/NF-kappaB complex	NFKB1 NFKB2	7.69e-04	4	239	2	GO:0033256
GeneOntologyCellularComponent	presynaptic active zone	NRXN1 NRXN2 FZD3 GRIA1 TENM3 EGFLAM CTNNA2	1.21e-03	141	239	7	GO:0048786
GeneOntologyCellularComponent	NF-kappaB complex	NFKB1 RELB	1.27e-03	5	239	2	GO:0071159
GeneOntologyCellularComponent	CKM complex	CDK8 CDK19	1.27e-03	5	239	2	GO:1990508
Domain	EGF-like_dom	VWDE SVEP1 STAB1 FAT2 FBN1 FBN2 FCGBP HMCN2 NRXN1 NRXN2 NID1 CUBN TEK EDIL3 MEGF6 HMCN1 TENM3 EGFLAM AGRN FBN3	6.84e-11	249	238	20	IPR000742
Domain	Ig-like_fold	MYBPH IL12RB2 OBSCN CNTN6 BTN2A2 NEO1 HMCN2 PTPRM NFKB1 CD101 NFKB2 PVR SDK1 IGLON5 PLXNA1 SEMA4D MXRA5 VSTM2A IGDCC3 RELB TEK ADAMTSL3 BTN2A1 MST1R LIFR LRRN4CL HMCN1 WFIKKN1 BTN2A3P EGFLAM FCRL4 BCAM MYBPC2	1.09e-10	706	238	33	IPR013783
Domain	EGF	VWDE SVEP1 STAB1 FAT2 FBN1 FBN2 FCGBP NRXN1 NRXN2 NID1 CUBN TEK EDIL3 MEGF6 HMCN1 TENM3 EGFLAM AGRN FBN3	1.86e-10	235	238	19	SM00181
Domain	EGF_3	VWDE SVEP1 STAB1 FAT2 FBN1 FBN2 HMCN2 NRXN1 NRXN2 NID1 CUBN TEK EDIL3 MEGF6 HMCN1 TENM3 EGFLAM AGRN FBN3	1.86e-10	235	238	19	PS50026
Domain	-	MYBPH IL12RB2 OBSCN CNTN6 BTN2A2 NEO1 PTPRM NFKB1 CD101 NFKB2 PVR SDK1 IGLON5 PLXNA1 SEMA4D MXRA5 VSTM2A IGDCC3 RELB TEK ADAMTSL3 BTN2A1 MST1R LIFR LRRN4CL HMCN1 WFIKKN1 EGFLAM FCRL4 BCAM MYBPC2	4.21e-10	663	238	31	2.60.40.10
Domain	EGF_CA	SVEP1 STAB1 FAT2 FBN1 FBN2 HMCN2 NID1 CUBN EDIL3 MEGF6 HMCN1 EGFLAM AGRN FBN3	5.13e-10	122	238	14	SM00179
Domain	EGF-like_Ca-bd_dom	SVEP1 STAB1 FAT2 FBN1 FBN2 HMCN2 NID1 CUBN EDIL3 MEGF6 HMCN1 EGFLAM AGRN FBN3	6.38e-10	124	238	14	IPR001881
Domain	EGF_1	VWDE SVEP1 STAB1 FAT2 FBN1 FBN2 HMCN2 NRXN1 NRXN2 NID1 CUBN TEK EDIL3 MEGF6 HMCN1 TENM3 EGFLAM AGRN FBN3	7.45e-10	255	238	19	PS00022
Domain	EGF-like_CS	VWDE SVEP1 STAB1 FAT2 FBN1 FBN2 HMCN2 NRXN1 NRXN2 NID1 CUBN TEK EDIL3 MEGF6 HMCN1 TENM3 EGFLAM AGRN FBN3	1.10e-09	261	238	19	IPR013032
Domain	EGF_2	VWDE SVEP1 STAB1 FAT2 FBN1 FBN2 HMCN2 NRXN1 NRXN2 NID1 CUBN TEK EDIL3 MEGF6 HMCN1 TENM3 EGFLAM AGRN FBN3	1.42e-09	265	238	19	PS01186
Domain	EGF	SVEP1 STAB1 FAT2 NRXN1 NRXN2 NID1 CUBN EDIL3 MEGF6 HMCN1 EGFLAM AGRN FBN3	8.05e-09	126	238	13	PF00008
Domain	IG_LIKE	MYBPH OBSCN CNTN6 BTN2A2 NEO1 HMCN2 PTPRM CD101 PVR SDK1 IGLON5 SEMA4D MXRA5 VSTM2A IGDCC3 TEK ADAMTSL3 BTN2A1 HMCN1 WFIKKN1 BTN2A3P FCRL4 BCAM MYBPC2	1.97e-08	491	238	24	PS50835
Domain	IG	MYBPH OBSCN CNTN6 BTN2A2 NEO1 HMCN2 PTPRM CD101 PVR SDK1 IGLON5 SEMA4D MXRA5 VSTM2A IGDCC3 ADAMTSL3 BTN2A1 HMCN1 WFIKKN1 FCRL4 BCAM MYBPC2	2.44e-08	421	238	22	SM00409
Domain	Ig_sub	MYBPH OBSCN CNTN6 BTN2A2 NEO1 HMCN2 PTPRM CD101 PVR SDK1 IGLON5 SEMA4D MXRA5 VSTM2A IGDCC3 ADAMTSL3 BTN2A1 HMCN1 WFIKKN1 FCRL4 BCAM MYBPC2	2.44e-08	421	238	22	IPR003599
Domain	Ig-like_dom	MYBPH OBSCN CNTN6 BTN2A2 NEO1 HMCN2 PTPRM CD101 PVR SDK1 IGLON5 SEMA4D MXRA5 VSTM2A IGDCC3 TEK ADAMTSL3 BTN2A1 HMCN1 WFIKKN1 BTN2A3P FCRL4 BCAM MYBPC2	3.12e-08	503	238	24	IPR007110
Domain	ASX_HYDROXYL	SVEP1 FBN1 FBN2 HMCN2 NRXN1 NID1 CUBN EDIL3 MEGF6 HMCN1 FBN3	5.97e-08	100	238	11	PS00010
Domain	IGc2	MYBPH OBSCN CNTN6 NEO1 HMCN2 SDK1 IGLON5 SEMA4D MXRA5 IGDCC3 ADAMTSL3 HMCN1 WFIKKN1 FCRL4 BCAM MYBPC2	6.04e-08	235	238	16	SM00408
Domain	Ig_sub2	MYBPH OBSCN CNTN6 NEO1 HMCN2 SDK1 IGLON5 SEMA4D MXRA5 IGDCC3 ADAMTSL3 HMCN1 WFIKKN1 FCRL4 BCAM MYBPC2	6.04e-08	235	238	16	IPR003598
Domain	Growth_fac_rcpt_	SVEP1 STAB1 CCN5 FBN1 FBN2 HMCN2 NID1 CCN3 CUBN TEK MEGF6 HMCN1 FBN3	1.05e-07	156	238	13	IPR009030
Domain	EGF-type_Asp/Asn_hydroxyl_site	SVEP1 FBN1 FBN2 HMCN2 NRXN1 NID1 CUBN EDIL3 MEGF6 HMCN1 FBN3	1.10e-07	106	238	11	IPR000152
Domain	Ig_I-set	MYBPH OBSCN CNTN6 NEO1 HMCN2 CD101 SDK1 IGLON5 MXRA5 IGDCC3 ADAMTSL3 HMCN1 WFIKKN1 MYBPC2	1.57e-07	190	238	14	IPR013098
Domain	I-set	MYBPH OBSCN CNTN6 NEO1 HMCN2 CD101 SDK1 IGLON5 MXRA5 IGDCC3 ADAMTSL3 HMCN1 WFIKKN1 MYBPC2	1.57e-07	190	238	14	PF07679
Domain	fn3	MYBPH IL12RB2 OBSCN CNTN6 NEO1 PTPRM SDK1 IGDCC3 TEK LIFR LRRN4CL EGFLAM MYBPC2	1.63e-07	162	238	13	PF00041
Domain	EGF_Ca-bd_CS	SVEP1 FBN1 FBN2 HMCN2 NID1 CUBN EDIL3 MEGF6 HMCN1 FBN3	4.46e-07	97	238	10	IPR018097
Domain	EGF_CA	SVEP1 FBN1 FBN2 HMCN2 NID1 CUBN EDIL3 MEGF6 HMCN1 FBN3	5.40e-07	99	238	10	PS01187
Domain	FN3	MYBPH IL12RB2 OBSCN CNTN6 NEO1 PTPRM SDK1 IGDCC3 TEK LIFR LRRN4CL EGFLAM MYBPC2	7.53e-07	185	238	13	SM00060
Domain	EGF_CA	SVEP1 FBN1 FBN2 HMCN2 NID1 CUBN MEGF6 HMCN1 FBN3	1.49e-06	86	238	9	PF07645
Domain	FN3	MYBPH IL12RB2 OBSCN CNTN6 NEO1 PTPRM SDK1 IGDCC3 TEK LIFR LRRN4CL EGFLAM MYBPC2	1.71e-06	199	238	13	PS50853
Domain	PRib_PP_synth_CS	PRPS2 PRPS1L1 PRPS1	2.04e-06	3	238	3	IPR000842
Domain	PRPP_SYNTHASE	PRPS2 PRPS1L1 PRPS1	2.04e-06	3	238	3	PS00114
Domain	FBN	FBN1 FBN2 FBN3	2.04e-06	3	238	3	IPR011398
Domain	FN3_dom	MYBPH IL12RB2 OBSCN CNTN6 NEO1 PTPRM SDK1 IGDCC3 TEK LIFR LRRN4CL EGFLAM MYBPC2	2.96e-06	209	238	13	IPR003961
Domain	GFP-like	SVEP1 STAB1 NID1 HMCN1	7.91e-06	11	238	4	IPR023413
Domain	-	SVEP1 STAB1 NID1 HMCN1	7.91e-06	11	238	4	2.40.155.10
Domain	NIDOGEN_G2	HMCN2 NID1 HMCN1	8.10e-06	4	238	3	PS50993
Domain	G2_nidogen/fibulin_G2F	HMCN2 NID1 HMCN1	8.10e-06	4	238	3	IPR006605
Domain	G2F	HMCN2 NID1 HMCN1	8.10e-06	4	238	3	PF07474
Domain	GFP	HMCN2 NID1 HMCN1	8.10e-06	4	238	3	IPR009017
Domain	cEGF	FBN1 FBN2 NID1 HMCN1 FBN3	1.70e-05	26	238	5	PF12662
Domain	cEGF	FBN1 FBN2 NID1 HMCN1 FBN3	1.70e-05	26	238	5	IPR026823
Domain	LamG	FAT2 NRXN1 NRXN2 COL18A1 EGFLAM AGRN	1.89e-05	44	238	6	SM00282
Domain	IPT_NFkappaB	NFKB1 NFKB2 RELB	2.01e-05	5	238	3	IPR033926
Domain	Pribosyltran_N	PRPS2 PRPS1L1 PRPS1	2.01e-05	5	238	3	PF13793
Domain	Pribosyl_synth	PRPS2 PRPS1L1 PRPS1	2.01e-05	5	238	3	PF14572
Domain	Rib-P_diPkinase	PRPS2 PRPS1L1 PRPS1	2.01e-05	5	238	3	IPR005946
Domain	Pribosyltran_N	PRPS2 PRPS1L1 PRPS1	2.01e-05	5	238	3	IPR029099
Domain	RHD_CS	NFKB1 NFKB2 RELB	2.01e-05	5	238	3	IPR030492
Domain	IPT	NFKB1 NFKB2 PLXNA1 RELB MST1R	2.07e-05	27	238	5	SM00429
Domain	hEGF	SVEP1 FBN2 EDIL3 MEGF6 FBN3	2.49e-05	28	238	5	PF12661
Domain	-	KIF21B DMXL1 NWD2 WDR90 DMWD PLXNA1 WDR24 SEMA6C SEMA4D DMXL2 DCAF4L2 MST1R WDR41 DCAF11 WIPI2	2.58e-05	333	238	15	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	KIF21B DMXL1 NWD2 WDR90 DMWD PLXNA1 WDR24 SEMA6C SEMA4D DMXL2 DCAF4L2 MST1R WDR41 DCAF11 WIPI2	2.76e-05	335	238	15	IPR015943
Domain	IGv	OBSCN BTN2A2 CD101 PVR BTN2A1 HMCN1 BTN2A3P	4.75e-05	75	238	7	SM00406
Domain	IPT	NFKB1 NFKB2 PLXNA1 RELB MST1R	4.90e-05	32	238	5	IPR002909
Domain	TB	FBN1 FBN2 FBN3	6.89e-05	7	238	3	PF00683
Domain	Laminin_G	FAT2 NRXN1 NRXN2 COL18A1 EGFLAM AGRN	9.35e-05	58	238	6	IPR001791
Domain	-	FBN1 FBN2 FBN3	1.09e-04	8	238	3	3.90.290.10
Domain	EGF_extracell	SVEP1 STAB1 TEK EDIL3 MEGF6 TENM3	1.13e-04	60	238	6	IPR013111
Domain	EGF_2	SVEP1 STAB1 TEK EDIL3 MEGF6 TENM3	1.13e-04	60	238	6	PF07974
Domain	LAM_G_DOMAIN	FAT2 NRXN1 NRXN2 EGFLAM AGRN	1.15e-04	38	238	5	PS50025
Domain	WD40_repeat_dom	KIF21B ITFG2 DMXL1 NWD2 WDR90 DMWD WDR24 DMXL2 DCAF4L2 TENM3 WDR41 DCAF11 WIPI2	1.19e-04	297	238	13	IPR017986
Domain	Rav1p_C	DMXL1 DMXL2	1.62e-04	2	238	2	PF12234
Domain	Dihydroorotase_CS	CD101 CAD	1.62e-04	2	238	2	IPR002195
Domain	Rav1p_C	DMXL1 DMXL2	1.62e-04	2	238	2	IPR022033
Domain	TB_dom	FBN1 FBN2 FBN3	1.62e-04	9	238	3	IPR017878
Domain	TB	FBN1 FBN2 FBN3	1.62e-04	9	238	3	PS51364
Domain	ig	OBSCN PTPRM PVR IGLON5 SEMA4D IGDCC3 ADAMTSL3 HMCN1 FCRL4 BCAM	1.68e-04	190	238	10	PF00047
Domain	Immunoglobulin	OBSCN PTPRM PVR IGLON5 SEMA4D IGDCC3 ADAMTSL3 HMCN1 FCRL4 BCAM	1.68e-04	190	238	10	IPR013151
Domain	RHD_dimer	NFKB1 NFKB2 RELB	2.30e-04	10	238	3	PF16179
Domain	REL_1	NFKB1 NFKB2 RELB	2.30e-04	10	238	3	PS01204
Domain	NFkB/Dor	NFKB1 NFKB2 RELB	2.30e-04	10	238	3	IPR000451
Domain	RHD_DNA_bind_dom	NFKB1 NFKB2 RELB	2.30e-04	10	238	3	IPR011539
Domain	RHD_dimer	NFKB1 NFKB2 RELB	2.30e-04	10	238	3	IPR032397
Domain	-	NFKB1 NFKB2 RELB	2.30e-04	10	238	3	2.60.40.340
Domain	RHD_DNA_bind	NFKB1 NFKB2 RELB	2.30e-04	10	238	3	PF00554
Domain	REL_2	NFKB1 NFKB2 RELB	2.30e-04	10	238	3	PS50254
Domain	Ig_V-set	OBSCN BTN2A2 CD101 PVR IGLON5 VSTM2A BTN2A1 HMCN1 BTN2A3P BCAM	2.44e-04	199	238	10	IPR013106
Domain	Pribosyltran	PRPS2 PRPS1L1 PRPS1	3.13e-04	11	238	3	PF00156
Domain	PRibTrfase_dom	PRPS2 PRPS1L1 PRPS1	4.13e-04	12	238	3	IPR000836
Domain	EGF_dom	STAB1 NID1 CUBN	4.13e-04	12	238	3	IPR024731
Domain	EGF_3	STAB1 NID1 CUBN	4.13e-04	12	238	3	PF12947
Domain	PRTase-like	PRPS2 PRPS1L1 PRPS1	4.13e-04	12	238	3	IPR029057
Domain	-	PRPS2 PRPS1L1 PRPS1	4.13e-04	12	238	3	3.40.50.2020
Domain	G2F	NID1 HMCN1	4.81e-04	3	238	2	SM00682
Domain	ConA-like_dom	SVEP1 BTN2A2 FAT2 NRXN1 NRXN2 PTPRM BTN2A1 COL18A1 EGFLAM AGRN	5.21e-04	219	238	10	IPR013320
Domain	SEMA	PLXNA1 SEMA6C SEMA4D MST1R	6.17e-04	31	238	4	PS51004
Domain	Semap_dom	PLXNA1 SEMA6C SEMA4D MST1R	6.17e-04	31	238	4	IPR001627
Domain	TIG	NFKB1 PLXNA1 RELB MST1R	6.17e-04	31	238	4	PF01833
Domain	Sema	PLXNA1 SEMA6C SEMA4D MST1R	6.17e-04	31	238	4	SM00630
Domain	Sema	PLXNA1 SEMA6C SEMA4D MST1R	6.17e-04	31	238	4	PF01403
Domain	WD40	KIF21B DMXL1 NWD2 WDR90 DMWD WDR24 DMXL2 DCAF4L2 WDR41 DCAF11 WIPI2	6.78e-04	268	238	11	SM00320
Domain	Kringle-like	KREMEN2 CCN5 MRC1 IGF2R	6.98e-04	32	238	4	IPR013806
Domain	Plexin_repeat	PLXNA1 SEMA6C SEMA4D MST1R	6.98e-04	32	238	4	IPR002165
Domain	PSI	PLXNA1 SEMA6C SEMA4D MST1R	6.98e-04	32	238	4	PF01437
Domain	WD40_repeat	KIF21B DMXL1 NWD2 WDR90 DMWD WDR24 DMXL2 DCAF4L2 WDR41 DCAF11 WIPI2	7.65e-04	272	238	11	IPR001680
Domain	WD_REPEATS_1	KIF21B DMXL1 NWD2 WDR90 DMWD WDR24 DMXL2 DCAF4L2 WDR41 DCAF11 WIPI2	9.15e-04	278	238	11	PS00678
Domain	WD_REPEATS_2	KIF21B DMXL1 NWD2 WDR90 DMWD WDR24 DMXL2 DCAF4L2 WDR41 DCAF11 WIPI2	9.42e-04	279	238	11	PS50082
Domain	WD_REPEATS_REGION	KIF21B DMXL1 NWD2 WDR90 DMWD WDR24 DMXL2 DCAF4L2 WDR41 DCAF11 WIPI2	9.42e-04	279	238	11	PS50294
Domain	-	AMT PDPR	9.54e-04	4	238	2	2.40.30.110
Domain	Amidase_2	PGLYRP3 PGLYRP1	9.54e-04	4	238	2	PF01510
Domain	EFG_IV	EFTUD2 GFM1	9.54e-04	4	238	2	SM00889
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CYLD CDK19 STAB1 MESD NRXN1 NRXN2 GCN1 DMXL2 RALGAPB SMG5 MEGF6 GIGYF2	6.62e-08	225	241	12	12168954
Pubmed	The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways.	NFKB1 NFKB2 RAG1 RELB	1.54e-07	8	241	4	27317259
Pubmed	Mediator complex cooperatively regulates transcription of retinoic acid target genes with Polycomb Repressive Complex 2 during neuronal differentiation.	CDK8 CDK19 EZH2	3.29e-07	3	241	3	26002960
Pubmed	Promoter regions of the human X-linked housekeeping genes PRPS1 and PRPS2 encoding phosphoribosylpyrophosphate synthetase subunit I and II isoforms.	PRPS2 PRPS1L1 PRPS1	3.29e-07	3	241	3	1314091
Pubmed	NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB.	NFKB1 NFKB2 RELB	3.29e-07	3	241	3	17008396
Pubmed	Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease.	BTN2A2 BTN2A1 BTN2A3P	3.29e-07	3	241	3	37356345
Pubmed	RANKL-Induced Btn2a2 - A T Cell Immunomodulatory Molecule - During Osteoclast Differentiation Fine-Tunes Bone Resorption.	BTN2A2 BTN2A1 BTN2A3P	3.29e-07	3	241	3	34421818
Pubmed	Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway.	NFKB1 NFKB2 RELB	3.29e-07	3	241	3	12969313
Pubmed	Cell-autonomous role for NF-kappa B in immature bone marrow B cells.	NFKB1 NFKB2 RAG1	3.29e-07	3	241	3	19265118
Pubmed	HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease.	NFKB1 NFKB2 PLCD4 RELB PRKAR2B	4.66e-07	23	241	5	9730685
Pubmed	The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases.	NFKB1 NFKB2 PLCD4 RELB PRKAR2B	4.66e-07	23	241	5	9278385
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KIF21B ACACA PPP1R12A OBSCN EXOC3 FN3K USP32 COBL NID1 NOP56 HSPA4L LOXHD1 CCT5 GIGYF2 CDK11B HYDIN	4.67e-07	497	241	16	36774506
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	NEK9 DMXL1 FZD6 MESD FBN1 FBN2 PVR NID1 CHPF2 HECTD1 PLXNA1 VCP CCN3 HSPA4L FKRP SPTLC2 ST3GAL2 EDIL3 BTN2A1 MST1R LIFR COL18A1 IGF2R TENM3 AGRN	1.14e-06	1201	241	25	35696571
Pubmed	Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	1583734
Pubmed	Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly.	FBN1 FBN2 FBN3	1.31e-06	4	241	3	25034023
Pubmed	NF-κB2 Controls the Migratory Activity of Memory T Cells by Regulating Expression of CXCR4 in a Mouse Model of Sjögren's Syndrome.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	28804991
Pubmed	Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	7729429
Pubmed	TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	1505523
Pubmed	Transfection of human endothelial cells with HIV-1 tat gene activates NF-kappa B and enhances monocyte adhesion.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	12427593
Pubmed	Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.	BTN2A2 BTN2A1 BTN2A3P	1.31e-06	4	241	3	26809444
Pubmed	Lack of nuclear factor-kappa B2/p100 causes a RelB-dependent block in early B lymphopoiesis.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	18505785
Pubmed	Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	20353939
Pubmed	Cutting edge: a short polypeptide domain of HIV-1-Tat protein mediates pathogenesis.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	10384093
Pubmed	Butyrophilin Btn2a2 inhibits TCR activation and phosphatidylinositol 3-kinase/Akt pathway signaling and induces Foxp3 expression in T lymphocytes.	BTN2A2 BTN2A1 BTN2A3P	1.31e-06	4	241	3	23589618
Pubmed	HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	10225209
Pubmed	Btn2a2 Regulates ILC2-T Cell Cross Talk in Type 2 Immune Responses.	BTN2A2 BTN2A1 BTN2A3P	1.31e-06	4	241	3	35145516
Pubmed	A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	7838536
Pubmed	Cdk8 is required for establishment of H3K27me3 and gene repression by Xist and mouse development.	CDK8 CDK19 EDIL3	1.31e-06	4	241	3	32439758
Pubmed	Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.	NFKB1 NFKB2 RELB	1.31e-06	4	241	3	8676466
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	FZD6 PVR SDK1 PLXNA1 SEMA6C SEMA4D FZD3 CUBN	1.69e-06	117	241	8	17145500
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	CDK8 KIF21B ACACA ITFG2 MYO10 DHX38 VPS16 EZH2 C2CD5 EDDM3A MESD ATL2 HECTD1 GCN1 WDR24 CAD PDCD6IP OTUD5 SPTLC2 FPGS RALGAPB SMURF1 TRMT2A CCT5 GIGYF2 CDK6	2.10e-06	1327	241	26	32694731
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	OBSCN CNTN6 PTPRM IGLON5 VSTM2A IGDCC3 TEK HMCN1 BCAM	2.14e-06	162	241	9	25826454
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CYLD PPP1R12A DHX38 HJURP OBSCN C2CD5 PPARGC1A MESD DMWD PMS2 PDCD6IP NOP56 SMURF1 ST3GAL2 CUBN ARHGAP5 COL18A1 IGF2R INTS13 LPP DDX3Y AGRN CDK6	2.29e-06	1084	241	23	11544199
Pubmed	Multiple signals converging on NF-kappaB.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	10209157
Pubmed	Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated molecules.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	18466468
Pubmed	The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	10592330
Pubmed	The effect of HIV-1 regulatory proteins on cellular genes: derepression of the IL-2 promoter by Tat.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	11385624
Pubmed	Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	10602464
Pubmed	Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	14678988
Pubmed	The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-kappa B-dependent mechanism.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	11827962
Pubmed	U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	12473373
Pubmed	Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	8724035
Pubmed	Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers.	EZH2 NFKB1 RELB	3.25e-06	5	241	3	21884980
Pubmed	Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	10400814
Pubmed	Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease.	NFKB1 NFKB2 RELB	3.25e-06	5	241	3	12879447
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	PRPS2 DAB2 C2CD5 JAK1 KSR1 MESD PTPRM NFKB2 PVR COBL ABHD16A SPTLC2 EDIL3 RIT2 IGF2R TENM3 BCAM AGRN	3.26e-06	719	241	18	35337019
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	PRPS2 SRMS PGAM1 DMXL1 CAPN8 PGAM4 PLXNA1 SEMA4D DMXL2 SMURF1 PLCD4 KCNH4 PRMT6 HARS2 KLHL12 CDK11B CDK6 PRPS1	4.01e-06	730	241	18	34857952
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	PSMB2 C2CD5 FN3K FBN2 PTPRM NID1 OS9 UPP1 HECTD1 GCN1 VCP PDCD6IP HSPA4L SPTLC2 SMCHD1 OSGEP CCT5 TRIM32 LPP GFM1 PRPS1	5.03e-06	974	241	21	28675297
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	PRPS2 VPS16 NEK9 JAK1 NEO1 PTPRM PVR ATL2 ABHD16A PLXNA1 PDPR FKRP SPTLC2 SMCHD1 FPGS RDH14 ENTPD4 HARS2 IGF2R CTNNA2 BCAM GFM1	5.52e-06	1061	241	22	33845483
Pubmed	Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	12810684
Pubmed	Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	8615004
Pubmed	VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	30026228
Pubmed	BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation.	BTN2A2 BTN2A1 BTN2A3P	6.47e-06	6	241	3	20208008
Pubmed	RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	12709443
Pubmed	T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	10671224
Pubmed	Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	9110146
Pubmed	HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	12485413
Pubmed	The nuclear receptor chicken ovalbumin upstream promoter transcription factor interacts with HIV-1 Tat and stimulates viral replication in human microglial cells.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	10644726
Pubmed	Trophoblast giant cells express NF-kappa B2 during early mouse development.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	10402669
Pubmed	HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	11522182
Pubmed	Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	23086447
Pubmed	Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	7800480
Pubmed	Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	10446807
Pubmed	Identification of Astrotactin2 as a Genetic Modifier That Regulates the Global Orientation of Mammalian Hair Follicles.	FZD6 EDIL3 TRIM32	6.47e-06	6	241	3	26418459
Pubmed	IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis.	NFKB1 NFKB2 RELB	6.47e-06	6	241	3	20200955
Pubmed	A long non-coding RNA specifically expressed in early embryos programs the metabolic balance in adult mice.	ACACA ACADM PGAM1 PPARGC1A PGAM4	7.28e-06	39	241	5	33059001
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	PPP1R12A PSMB2 EZH2 PGAM1 MPRIP PRPS1L1 NFKB1 NFKB2 USP32 VCP CAD PDCD6IP OTUD5 SMCHD1 RELB COL18A1 CCT5 GIGYF2 WIPI2 PRPS1	7.80e-06	922	241	20	27609421
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	CYLD EXOC3 VPS16 C2CD5 USP32 DMXL2 OTUD5 USP6	9.21e-06	147	241	8	29576527
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ACACA MYO10 MTG2 OBSCN MPRIP NFKB2 COBL WDR90 DMWD FEM1A HECTD1 GCN1 PLXNA1 WDR24 SEMA6C RELB SMG5 MST1R IGF2R MEGF6 BCAM AGRN	1.04e-05	1105	241	22	35748872
Pubmed	Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation.	NFKB1 NFKB2 RELB	1.13e-05	7	241	3	11511100
Pubmed	Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB.	NFKB1 NFKB2 RELB	1.13e-05	7	241	3	10580107
Pubmed	The cluster of BTN genes in the extended major histocompatibility complex.	BTN2A2 BTN2A1 BTN2A3P	1.13e-05	7	241	3	11170752
Pubmed	Extracellular HIV type 1 Tat protein induces CD69 expression through NF-kappaB activation: possible correlation with cell surface Tat-binding proteins.	NFKB1 NFKB2 RELB	1.13e-05	7	241	3	10480634
Pubmed	The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.	NFKB1 NFKB2 RELB	1.13e-05	7	241	3	10644332
Pubmed	Expression and subcellular distribution of rel/NF kappa B transcription factors in the preimplantation mouse embryo: novel kappa B binding activities in the blastocyst stage embryo.	NFKB1 NFKB2 RELB	1.13e-05	7	241	3	9854797
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	EFCAB5 ACADM PEPD TRUB1 PGAM1 NDUFV1 GCN1 VCP PDCD6IP NOP56 ATG7 HSPA4L SPTLC2 PRMT6 IGF2R CCT5 DDX3Y CDK6 PRPS1	1.37e-05	878	241	19	37223481
Pubmed	Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.	ACADM DHX38 VPS16 JAK1 FBN2 NOP56 IGF2R AGRN	1.42e-05	156	241	8	29961565
Pubmed	Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development.	NFKB1 NFKB2 RELB	1.79e-05	8	241	3	27457956
Pubmed	Nitric oxide inhibits HIV tat-induced NF-kappaB activation.	NFKB1 NFKB2 RELB	1.79e-05	8	241	3	10393859
Pubmed	IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.	NFKB1 NFKB2 RELB	1.79e-05	8	241	3	18299349
Pubmed	Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells.	NFKB1 NFKB2 RELB	1.79e-05	8	241	3	9792375
Pubmed	In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.	NFKB1 NFKB2 RELB	1.79e-05	8	241	3	7690421
Pubmed	A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors.	FZD6 NID1 RAG1 FZD3	2.14e-05	24	241	4	9096311
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PPP1R12A PGAM1 NDUFV1 MPRIP NWD2 NRXN2 PGAM4 SORCS2 VCP CPEB2 DMXL2 CAD PDCD6IP HSPA4L SMURF1 DPYSL4 GRIA1 ARHGAP5 FBXL16 CCT5 CPEB4 PRKAR2B DDX3Y CTNNA2 PRPS1	2.33e-05	1431	241	25	37142655
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	NDUFV1 EFTUD2 NWD2 NRXN1 NRXN2 DHX35 GCN1 VCP DMXL2 CAD PDCD6IP NOP56 SMURF1 DPYSL4 EDIL3 TRIM32 DROSHA CPEB4 DDX3Y CDK11B AGRN	2.42e-05	1082	241	21	38697112
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	FBN1 FBN2 NID1 COL18A1 AGRN	2.52e-05	50	241	5	23658023
Pubmed	Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly.	FBN1 FBN2 MEGF6	2.68e-05	9	241	3	12122015
Pubmed	RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.	NFKB1 NFKB2 RELB	2.68e-05	9	241	3	12505990
Pubmed	Homeostatic apoptosis prevents competition-induced atrophy in follicular B cells.	NFKB2 RAG1 RELB	2.68e-05	9	241	3	34289356
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	ACACA VWDE FBN2 OS9 CHPF2 GCN1 PLXNA1 CAD SMCHD1 LIFR COL18A1 IGF2R CCT5 DDX3Y PRPS1	2.83e-05	613	241	15	22268729
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PRPS2 POP7 ACACA ACADM PPP1R12A DHX38 PSMB2 PEPD NEK9 PDCD4 EFTUD2 IRF2BPL HECTD1 GCN1 VCP PDCD6IP ATG7 HSPA4L OSGEP PRMT6 CCT5 INTS13 LPP DCAF11 PRPS1	3.06e-05	1455	241	25	22863883
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	FBN1 FBN2 HMCN2 NID1 COL18A1 MEGF6 HMCN1 AGRN	3.25e-05	175	241	8	28071719
Pubmed	HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis.	HECTD1 GCN1 VCP HSPA4L URGCP TRMT2A	3.29e-05	87	241	6	33711283
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	EFCAB5 ACACA DACT2 SVEP1 STAB1 MESD FBN2 PVR PGAM4 PMS2P3 NOP56 SPTLC2 SMCHD1 LOXHD1	3.56e-05	552	241	14	10737800
Pubmed	Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol.	NFKB1 NFKB2 RELB	3.80e-05	10	241	3	11579140
Pubmed	Regulation of NF-κB by the p105-ABIN2-TPL2 complex and RelAp43 during rabies virus infection.	NFKB1 NFKB2 RELB	3.80e-05	10	241	3	29084252
Pubmed	Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia.	NFKB1 NFKB2 RELB	3.80e-05	10	241	3	12167619
Pubmed	Eda-activated RelB recruits an SWI/SNF (BAF) chromatin-remodeling complex and initiates gene transcription in skin appendage formation.	KREMEN2 NFKB1 NFKB2 RELB	4.04e-05	28	241	4	30037996
Pubmed	A protein interaction landscape of breast cancer.	DAB2 EZH2 MPRIP OS9 PMS2 NOP56 HSPA4L SPTLC2 SMG5 XRCC3 IGF2R LPP CTNNA2 AJUBA CDK6	4.15e-05	634	241	15	34591612
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ACADM PPP1R12A EXOC3 VPS16 NDUFV1 EFTUD2 DHX35 SPTLC2 TRMT2A TRIM32 INTS13 PRKAR2B WDR41 GFM1	4.16e-05	560	241	14	35241646
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYBPH OBSCN CNTN6 NEO1 HMCN2 PTPRM CD101 SDK1 MXRA5 IGDCC3 ADAMTSL3 HMCN1 WFIKKN1 MYBPC2	1.19e-10	161	156	14	593
GeneFamily	Fibronectin type III domain containing	MYBPH IL12RB2 OBSCN CNTN6 NEO1 PTPRM SDK1 IGDCC3 TEK LIFR LRRN4CL EGFLAM MYBPC2	1.31e-09	160	156	13	555
GeneFamily	Immunoglobulin like domain containing	NEO1 HMCN2 PTPRM CD101 PVR SDK1 IGLON5 SEMA4D MXRA5 TEK ADAMTSL3 FCRL4 BCAM	1.28e-08	193	156	13	594
GeneFamily	Ankyrin repeat domain containing\|NF-kappa B complex subunits	NFKB1 NFKB2 RELB	6.22e-06	5	156	3	1254
GeneFamily	Cyclin dependent kinases	CDK8 CDK19 CDK11B CDK6	6.88e-05	26	156	4	496
GeneFamily	WD repeat domain containing	KIF21B DMXL1 WDR90 DMWD WDR24 DMXL2 DCAF4L2 WDR41 DCAF11 WIPI2	9.44e-05	262	156	10	362
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTN2A2 BTN2A1 BTN2A3P	2.66e-04	15	156	3	458
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	BTN2A2 PVR BTN2A1 BCAM	3.83e-04	40	156	4	592
GeneFamily	Bisphosphoglycerate phosphatases	PGAM1 PGAM4	4.39e-04	4	156	2	1082
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CD163 CD101 PVR MRC1 SEMA4D TEK MST1R LIFR IGF2R FCRL4 BCAM	6.34e-04	394	156	11	471
GeneFamily	CD molecules\|MRH domain containing	OS9 IGF2R	1.08e-03	6	156	2	1233
GeneFamily	CYR61/CTGF/NOV matricellular proteins	CCN5 CCN3	1.08e-03	6	156	2	1046
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	CD163 STAB1 MRC1	1.58e-03	27	156	3	1253
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYBPH MYBPC2	2.00e-03	8	156	2	658
GeneFamily	Fibulins	HMCN2 HMCN1	2.00e-03	8	156	2	556
GeneFamily	Adenosine receptors\|V-set domain containing	BTN2A2 CD101 PVR IGLON5 VSTM2A BTN2A1	2.93e-03	163	156	6	590
GeneFamily	Ubiquitin like modifier activating enzymes	UBA7 ATG7	3.18e-03	10	156	2	100
GeneFamily	G protein-coupled receptors, Class F frizzled	FZD6 FZD3	3.87e-03	11	156	2	286
GeneFamily	DEAH-box helicases	DHX38 DHX35	8.20e-03	16	156	2	500
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP4 ARHGAP5 ARHGAP18	9.18e-03	50	156	3	721
GeneFamily	Heat shock 70kDa proteins	HSPA12B HSPA4L	9.24e-03	17	156	2	583
Coexpression	NABA_ECM_GLYCOPROTEINS	VWDE SVEP1 CCN5 FBN1 FBN2 HMCN2 NID1 CCN3 MXRA5 EDIL3 HMCN1 EGFLAM AGRN FBN3	4.24e-09	196	241	14	M3008
Coexpression	NABA_CORE_MATRISOME	VWDE SVEP1 CCN5 FBN1 FBN2 HMCN2 NID1 CCN3 MXRA5 EDIL3 COL18A1 HMCN1 EGFLAM AGRN FBN3	4.46e-08	275	241	15	M5884
Coexpression	NABA_ECM_GLYCOPROTEINS	VWDE SVEP1 CCN5 FBN1 FBN2 HMCN2 NID1 CCN3 EDIL3 HMCN1 EGFLAM AGRN	2.25e-07	191	241	12	MM17059
Coexpression	NABA_CORE_MATRISOME	VWDE SVEP1 CCN5 FBN1 FBN2 HMCN2 NID1 CCN3 EDIL3 COL18A1 HMCN1 EGFLAM AGRN	1.46e-06	270	241	13	MM17057
Coexpression	NABA_MATRISOME	VWDE SVEP1 CCN5 FBN1 FBN2 HMCN2 VWC2L NID1 PLXNA1 CCN3 SEMA6C SEMA4D EGLN3 MXRA5 NRTN ADAMTSL3 EDIL3 COL18A1 MEGF6 HMCN1 WFIKKN1 EGFLAM AGRN FBN3	2.89e-05	1026	241	24	M5889
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IL12RB2 CNTN6 FBN2 HMCN2 VWC2L SDK1 MXRA5 IGDCC3 TEK ARHGAP18 FBN3	4.48e-09	181	240	11	154d5e586cab25155c6d06dfe6ae01203b88e0fb
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPA12B CNTN6 PTPRM EDIL3 LIFR LOXHD1 DDX3Y EGFLAM BCAM ARHGAP18	4.56e-08	177	240	10	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CAPN8 PPARGC1A SYCP2 FBN2 NRXN1 SDK1 LOXHD1 HMCN1 HYDIN	6.57e-08	184	240	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CAPN8 PPARGC1A SYCP2 FBN2 NRXN1 SDK1 LOXHD1 HMCN1 HYDIN	6.57e-08	184	240	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CAPN8 PPARGC1A SYCP2 FBN2 NRXN1 SDK1 LOXHD1 HMCN1 HYDIN	6.57e-08	184	240	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	RERG SVEP1 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1 TENM3	8.88e-08	190	240	10	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RERG SVEP1 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1 TENM3	9.33e-08	191	240	10	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RERG SVEP1 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1 TENM3	9.79e-08	192	240	10	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 DAB2 STAB1 NRXN1 NRXN2 NID1 MRC1 VIPR1 TEK LIFR	1.03e-07	193	240	10	2483bb7f398e4fa0ef09c8bd584ed25703853f03
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RERG OBSCN CCN5 FBN1 NID1 MXRA5 ADAMTSL3 EDIL3 COL18A1 LPP	1.08e-07	194	240	10	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	RERG SVEP1 CCN5 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1	1.13e-07	195	240	10	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RERG SVEP1 CCN5 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1	1.19e-07	196	240	10	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	RERG SVEP1 CCN5 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1	1.31e-07	198	240	10	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RERG SVEP1 CCN5 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1	1.31e-07	198	240	10	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	HSPA12B FZD6 FBN2 PTPRM EDIL3 LIFR HMCN1 EGFLAM BCAM ARHGAP18	1.37e-07	199	240	10	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG SVEP1 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1 TENM3	1.43e-07	200	240	10	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG SVEP1 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1 TENM3	1.43e-07	200	240	10	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG MYO10 SVEP1 FBN1 NID1 SDK1 GRIA1 ADAMTSL3 HMCN1 TENM3	1.43e-07	200	240	10	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG SVEP1 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1 TENM3	1.43e-07	200	240	10	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG SVEP1 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1 TENM3	1.43e-07	200	240	10	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Biopsy_Other_PF-Mesenchymal\|Biopsy_Other_PF / Sample group, Lineage and Cell type	RERG SVEP1 CCN5 FBN1 NID1 MXRA5 AOX1 EDIL3 COL18A1 HMCN1	1.43e-07	200	240	10	d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070
ToppCell	control-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FN3K SAG ZNF589 DHX35 RAG1 EGLN3 TTC24 RFXAP PRMT6	3.41e-07	168	240	9	affc39c7568b7df4b36af6f5b0e3702a18b6268c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DAB2 SVEP1 FBN1 FBN2 NID1 MXRA5 EDIL3 COL18A1 PRKAR2B	3.58e-07	169	240	9	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	OBSCN CD163 STAB1 FCGBP MRC1 DMXL2 NRAP CPEB4 ARHGAP18	3.76e-07	170	240	9	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	Ionocyte-iono-2\|World / Class top	CDK8 SYCP2 PTPRM NFKB1 UPP1 PDPR PLCD4 COL18A1 RAVER2	4.36e-07	173	240	9	e5ec28ccc5e048fd98de4c876e5c53b866b66228
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RERG OBSCN NWD2 HMCN2 NID1 DPYSL4 PLCD4 ADAMTSL3 COL18A1	5.29e-07	177	240	9	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	RERG CHRM2 SVEP1 CCN5 FBN1 NID1 AOX1 GRIA1 ADAMTSL3	5.81e-07	179	240	9	10fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCell	390C-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PTPRM USP32 TTC24 FKRP RALGAPB RDH14 RELB COL18A1 DROSHA	5.81e-07	179	240	9	3edcd1356e49b1f5514c585861999e079ca5e579
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	RERG SVEP1 FBN1 NID1 SDK1 GRIA1 ADAMTSL3 HMCN1 TENM3	8.37e-07	187	240	9	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MPRIP NRXN1 NID1 ADAMTSL3 IGF2R PRKAR2B EGFLAM AJUBA CDK6	9.15e-07	189	240	9	26cfe5b7e7f477f225f4e9f25f983f432f01e183
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	RERG MYO10 OBSCN CHRM2 NID1 ADAMTSL3 EDIL3 COL18A1 EGFLAM	9.15e-07	189	240	9	d7ed96add29f219183c802895fbff519b627f635
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MPRIP NRXN1 NID1 ADAMTSL3 IGF2R PRKAR2B EGFLAM AJUBA CDK6	9.56e-07	190	240	9	2ab604d35456beba71c25511e0f819000e6642d2
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRXN1 NID1 ST3GAL2 ADAMTSL3 IGF2R PRKAR2B EGFLAM AJUBA CDK6	9.56e-07	190	240	9	951e067d14412db67dc3babcdf61e41717d7b429
ToppCell	IPF-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	ACACA CNTN6 CAPN8 SORCS2 ATL2 UGT1A8 HMCN1 LPP BCAM	1.04e-06	192	240	9	356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG MYO10 SVEP1 FBN1 NID1 SDK1 AOX1 GRIA1 HMCN1	1.09e-06	193	240	9	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	RERG MYO10 SVEP1 FBN1 NID1 SDK1 GRIA1 HMCN1 TENM3	1.19e-06	195	240	9	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG SVEP1 FBN1 NID1 SDK1 AOX1 GRIA1 ADAMTSL3 HMCN1	1.24e-06	196	240	9	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG OBSCN CHRM2 NID1 DPYSL4 ADAMTSL3 COL18A1 PRKAR2B EGFLAM	1.29e-06	197	240	9	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG OBSCN CHRM2 NID1 DPYSL4 ADAMTSL3 COL18A1 PRKAR2B EGFLAM	1.29e-06	197	240	9	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	RERG SVEP1 FBN1 SDK1 VIPR1 MXRA5 LIFR HMCN1 EGFLAM	1.35e-06	198	240	9	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	Fibroblasts\|World / lung cells shred on cell class, cell subclass, sample id	RERG SVEP1 CCN5 FBN1 NID1 MXRA5 AOX1 COL18A1 TENM3	1.40e-06	199	240	9	e2b6752fcabd5249a166486ae6796f2c97c1fcaf
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	RERG SVEP1 CCN5 FBN1 NID1 MXRA5 AOX1 GRIA1 HMCN1	1.40e-06	199	240	9	7a227c239afdaebcac84644d9b2653a5f1a4be71
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SVEP1 CCN5 FBN1 NRXN2 NID1 AOX1 ADAMTSL3 LRRN4CL HMCN1	1.46e-06	200	240	9	44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	RERG PPP1R12A MPRIP FBN2 NID1 DMWD CCN3 ADAMTSL3 EDIL3	1.46e-06	200	240	9	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	Biopsy_IPF-Mesenchymal\|Biopsy_IPF / Sample group, Lineage and Cell type	RERG SVEP1 CCN5 FBN1 NID1 MXRA5 AOX1 COL18A1 LRRN4CL	1.46e-06	200	240	9	bb605b373caf3f873dc1b87d712704568e0d6040
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG SVEP1 FBN1 NID1 SDK1 GRIA1 ADAMTSL3 HMCN1 TENM3	1.46e-06	200	240	9	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	cellseq2-Mesenchymal-Fibroblastic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SVEP1 CCN5 FBN1 NRXN2 NID1 AOX1 ADAMTSL3 LRRN4CL HMCN1	1.46e-06	200	240	9	1c10597edd532bf172ca09870a937d35e2585081
ToppCell	Parenchymal-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RERG SVEP1 CCN5 FBN1 NID1 MXRA5 AOX1 COL18A1 HMCN1	1.46e-06	200	240	9	2e525c0d9684e7a2275edb04e1addb6fc6a872e5
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SVEP1 CCN5 FBN1 NRXN2 NID1 AOX1 ADAMTSL3 LRRN4CL HMCN1	1.46e-06	200	240	9	440dda48b09c6a8581b7ca634b0d67f1ecacf65e
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	RERG PPP1R12A HMCN2 EDIL3 COL18A1 LPP EGFLAM BCAM	2.71e-06	161	240	8	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	RERG OBSCN NID1 ADAMTSL3 EDIL3 COL18A1 PRKAR2B EGFLAM	4.24e-06	171	240	8	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPA12B PTPRM SORCS2 RAG1 LRRN4CL HMCN1 LPP AJUBA	5.25e-06	176	240	8	7292e014b8f697f0c2e9f47c48333de95cb44a69
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPA12B PTPRM SORCS2 RAG1 LRRN4CL HMCN1 LPP AJUBA	5.25e-06	176	240	8	88ca2f83d8301633232735f39b0683efe49d0b86
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNTN6 CAPN8 NRXN1 SETMAR HMCN1 WFIKKN1 GALNT9 BCAM	5.47e-06	177	240	8	75cb2067a3f2d1b5a964890b02b604d1e79bd163
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RERG NRXN1 NID1 ADAMTSL3 IGF2R EGFLAM AJUBA CDK6	5.94e-06	179	240	8	56db12467b445f2b8ef92af50779eeab10413eb2
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	SVEP1 FBN1 FBN2 MXRA5 ADAMTSL3 HMCN1 TENM3 GUCA1A	6.45e-06	181	240	8	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HJURP STAB1 FZD6 NRXN2 EGLN3 PGLYRP1 MEGF6 ACSM2B	6.71e-06	182	240	8	d22ab50b135482915687c70e6dad29bfe2bb2c68
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RERG SVEP1 FBN1 NID1 ADAMTSL3 COL18A1 LRRN4CL HMCN1	6.71e-06	182	240	8	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL12RB2 DAB2 CD163 STAB1 MRC1 DOK2 ARHGAP4 CX3CR1	6.71e-06	182	240	8	de15a77b8d3527638bea5b04e0b2af03ac93bc18
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	DACT2 HSPA12B CCN5 PPARGC1A FBN1 NID1 MXRA5 CTNNA2	7.57e-06	185	240	8	506eee2c1b6e8acec3aa8b2c66868010006c4c14
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL12RB2 DAB2 CD163 STAB1 MRC1 DOK2 ARHGAP4 CX3CR1	7.87e-06	186	240	8	c0a58e43a813441d3a1708236737b15db8bea10e
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IL12RB2 MTG2 CHPF2 DHX35 GCN1 ST3GAL2 IGF2R CDK6	8.19e-06	187	240	8	4527d6426f2c4397e47f12439a13a8c14fd2aab2
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG MYO10 OBSCN CHRM2 NID1 ADAMTSL3 EDIL3 PRKAR2B	8.19e-06	187	240	8	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RERG CHRM2 SVEP1 FBN2 PTPRM NID1 VSTM2A CUBN	8.19e-06	187	240	8	d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCell	facs-Heart-RA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 ATL2 TEK LIFR IGF2R MEGF6 HMCN1 BCAM	8.51e-06	188	240	8	4ddb11a90bf3baa7237bde304db44dfcc56aed52
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RERG OBSCN NID1 ADAMTSL3 EDIL3 COL18A1 PRKAR2B EGFLAM	8.51e-06	188	240	8	ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCell	facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 ATL2 TEK LIFR IGF2R MEGF6 HMCN1 BCAM	8.51e-06	188	240	8	e47e66906922d5c69b1aafe28face0787d3fc563
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG MYO10 OBSCN CHRM2 NID1 ADAMTSL3 EDIL3 PRKAR2B	8.51e-06	188	240	8	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 FZD6 SEMA4D TEK LIFR IGF2R MEGF6 HMCN1	8.85e-06	189	240	8	fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RERG NRXN1 NID1 ADAMTSL3 IGF2R EGFLAM AJUBA CDK6	8.85e-06	189	240	8	ca3a04c202afc32aa11d17154066ef7dc6d01405
ToppCell	droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DMWD SMURF1 HEXD RAB44 ZNF446 MST1R IGF2R	9.16e-06	136	240	7	a43b3db1754c619d328a26a2ba6af4756629a723
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RERG NRXN1 NID1 ADAMTSL3 PRKAR2B EGFLAM AJUBA CDK6	9.19e-06	190	240	8	979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RERG MYO10 OBSCN NID1 ADAMTSL3 EDIL3 COL18A1 LPP	9.19e-06	190	240	8	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RERG MYO10 OBSCN NID1 ADAMTSL3 EDIL3 COL18A1 LPP	9.19e-06	190	240	8	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RERG MYO10 OBSCN CCN5 NID1 ADAMTSL3 EDIL3 COL18A1	9.55e-06	191	240	8	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RERG SVEP1 FBN1 NID1 ADAMTSL3 LRRN4CL LPP EGFLAM	9.55e-06	191	240	8	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	RERG SVEP1 CCN5 FBN1 GRIA1 ADAMTSL3 HMCN1 SAMD11	9.55e-06	191	240	8	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	RERG SVEP1 CCN5 FBN1 GRIA1 ADAMTSL3 HMCN1 SAMD11	9.55e-06	191	240	8	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RERG MYO10 OBSCN CCN5 NID1 ADAMTSL3 EDIL3 COL18A1	9.55e-06	191	240	8	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	OBSCN FZD6 TEK ADAMTSL3 LIFR MEGF6 HMCN1 BCAM	9.92e-06	192	240	8	1990dc8a81594018a5bf596be99d0b5f0af0f58f
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL12RB2 DAB2 CD163 STAB1 MRC1 DOK2 ARHGAP4 CX3CR1	9.92e-06	192	240	8	453c11f468117ffdd8c248fee1e5bb1f5401cc33
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	OBSCN FZD6 TEK ADAMTSL3 LIFR MEGF6 HMCN1 BCAM	9.92e-06	192	240	8	845cc9c18b4436b07dd3ce7980052683937546d2
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	OBSCN FZD6 TEK ADAMTSL3 LIFR MEGF6 HMCN1 BCAM	9.92e-06	192	240	8	c72a082c93a8825adbfef37f889ba3a7052f201b
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RERG NRXN1 NID1 ADAMTSL3 PRKAR2B EGFLAM AJUBA CDK6	9.92e-06	192	240	8	063e119c4b58957643908f667e6cfd6f7517fd03
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG MYO10 SVEP1 NID1 SDK1 GRIA1 ADAMTSL3 HMCN1	1.03e-05	193	240	8	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO10 SVEP1 CCN5 FBN1 NID1 SDK1 AOX1 GRIA1	1.07e-05	194	240	8	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Control-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	RERG SVEP1 CCN5 NID1 SDK1 AOX1 GRIA1 HMCN1	1.07e-05	194	240	8	3c2266772c5b56e8e02a461e5193e29588028ee9
ToppCell	Control-Stromal-Myofibroblast\|Control / Disease state, Lineage and Cell class	RERG SVEP1 CCN5 NID1 SDK1 AOX1 GRIA1 HMCN1	1.11e-05	195	240	8	ffcf76cd72e43d8cf1058a49c76e0956065038bc
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRPS2 STK17A PPP1R12A FBN2 LANCL3 ADAMTSL3 LRRN4CL PRKAR2B	1.11e-05	195	240	8	55b4030f078173b0136990fae87b6eaf44c58f33
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRPS2 STK17A PPP1R12A FBN2 LANCL3 ADAMTSL3 LRRN4CL PRKAR2B	1.11e-05	195	240	8	19347b7e8d3ea67e0fddd948078abcab9d364a2d
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SVEP1 FBN1 NID1 MXRA5 EDIL3 LIFR COL18A1 PRKAR2B	1.15e-05	196	240	8	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	droplet-Heart-nan-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 ATL2 SEMA4D TEK LIFR IGF2R MEGF6 HMCN1	1.15e-05	196	240	8	e386526332138e636aef2542c11316347a45689c
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RERG PPP1R12A CCN5 NID1 ADAMTSL3 EDIL3 COL18A1 LPP	1.15e-05	196	240	8	754a3613340932563cd8424d775e18b93c3a1aaa
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 FZD6 TEK COL18A1 IGF2R MEGF6 HMCN1 AJUBA	1.15e-05	196	240	8	dbf154b3d166ffd07be717dac8d8a3350ac63e16
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 FZD6 TEK COL18A1 IGF2R MEGF6 HMCN1 AJUBA	1.15e-05	196	240	8	7d5eaed189aa6116f3799be010139fb675ec65e0
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 DAB2 STAB1 NRXN2 NID1 MRC1 TEK LIFR	1.20e-05	197	240	8	d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 DAB2 STAB1 JAK1 NID1 MRC1 TEK LIFR	1.20e-05	197	240	8	a6aaa6faea348291023f0bc4b0f83fbc67d91da6
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 DAB2 STAB1 NRXN2 NID1 MRC1 TEK LIFR	1.20e-05	197	240	8	412091994196a06c2779b4c2cfed84be889a5f8d
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 DAB2 STAB1 JAK1 NID1 MRC1 TEK LIFR	1.20e-05	197	240	8	deefb492b5f0e6014144bd465c4a6ae4206e8739
ToppCell	Bronchial_Brush-Epithelial-Basal_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	DACT2 MXRA5 EDIL3 COL18A1 MEGF6 HMCN1 BCAM AJUBA	1.20e-05	197	240	8	f5d87824c0020c95d89e069fd9f70b49e5d5fcea
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	CYLD ITFG2 PSMB2 PVR ZNF589 DPYSL4 SMG5 ZNF446 LPP HYI WIPI2	7.85e-06	195	241	11	4117_DN
Drug	Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	ITFG2 PSMB2 EVI5 PVR COBL SPTLC2 FPGS ST3GAL2 RFNG ENTPD4 TENM3	7.85e-06	195	241	11	3452_UP
Drug	2,6-diaminonebularine	PRPS2 PRPS1L1 EFTUD2 PRPS1	8.12e-06	13	241	4	CID000072200
Drug	haloperidol; Up 200; 10uM; PC3; HT_HG-U133A	KSR1 UBA7 SEMA4D SMURF1 ST3GAL2 RELB SMG5 ENTPD4 COL18A1 TRMT2A BCAM	9.07e-06	198	241	11	1203_UP
Drug	NSC105327	CDK8 CDK19 NFKB1 NFKB2 RELB CDK11B CDK6	9.28e-06	70	241	7	CID005318433
Drug	Tropine [120-29-6]; Up 200; 28.4uM; PC3; HT_HG-U133A	STK17A NEK9 KSR1 PVR COBL CCN3 SEMA4D SMG5 DOK2 EDIL3 DDX3Y	9.51e-06	199	241	11	5790_UP
Drug	NSC294601	NFKB1 NFKB2 RELB	1.15e-05	5	241	3	CID000325606
Drug	AC1MVXUL	NFKB1 NFKB2 RELB	1.15e-05	5	241	3	CID003715266
Drug	methyl iodoacetate	PRPS2 PRPS1L1 PRPS1	2.29e-05	6	241	3	CID006429536
Drug	APP-MP	PRPS2 PRPS1L1 PRPS1	2.29e-05	6	241	3	CID003081102
Drug	pyrimidine-5-nucleotide	PRPS2 PRPS1L1 PRPS1	2.29e-05	6	241	3	CID000440040
Drug	NSC-692968	NFKB1 NFKB2 PDPR RELB DMBX1 COL18A1 BCAM	3.34e-05	85	241	7	CID000392472
Drug	Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HG-U133A	PSMB2 FBN1 ZNF544 PTPRM ZNF589 CCN3 URGCP DCAF11 HYI WIPI2	4.21e-05	193	241	10	1961_DN
Drug	Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A	KREMEN2 CDK19 PSMB2 PDCD4 STAB1 EVI5 ST3GAL2 RFNG ENTPD4 HYI	4.21e-05	193	241	10	3474_UP
Drug	Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; HL60; HG-U133A	CALCOCO2 ACACA ITFG2 BCKDHA CHPF2 VCP CAD FPGS SMG5 BTN2A1	4.60e-05	195	241	10	2000_DN
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	CYLD CDK19 BTN2A2 SEMA4D FKRP RELB SMG5 ZNF446 ARHGAP4 RAVER2	4.60e-05	195	241	10	2875_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	EZH2 GCN1 PLXNA1 SEMA4D CAD FPGS ST3GAL2 SMG5 DOK2 URGCP	5.01e-05	197	241	10	1732_DN
Drug	Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A	STK17A PPP1R12A PDCD4 SVEP1 UPP1 AMT FKRP FPGS XRCC3 ENTPD4	5.01e-05	197	241	10	3459_UP
Drug	Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A	PDCD4 NEO1 ATL2 SPTLC2 FPGS SMURF1 ZNF446 BTN2A1 LPP DCAF11	5.01e-05	197	241	10	2638_DN
Drug	phytate	IP6K1 SAG NFKB1 NFKB2 PGAM4 AOX1 GRIA1 RELB COL18A1	5.16e-05	159	241	9	CID000000890
Drug	Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CYLD KREMEN2 PSMB2 NEO1 PVR DMWD DMXL2 RELB ZNF446 AGRN	5.23e-05	198	241	10	2841_UP
Drug	Tomatidine [77-59-8]; Down 200; 9.6uM; PC3; HT_HG-U133A	ITFG2 CDK19 PSMB2 BTN2A2 COBL DHX35 DMWD PMS2 MST1R LPP	5.46e-05	199	241	10	5808_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HG-U133A	ACACA ACADM ITFG2 CDK19 DMXL1 COBL MST1R COL18A1 MEGF6 GUCA1A	5.46e-05	199	241	10	418_DN
Drug	paracrystals	PRPS2 PRPS1L1 JAK1 MESD FBN2 VCP ATG7 CDK6 PRPS1	5.68e-05	161	241	9	CID000004685
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN2 FBN3	4.92e-07	3	234	3	DOID:65 (implicated_via_orthology)
Disease	Weight Gain	ACADM MYO10 EZH2 MPRIP NID1 RFNG PRPS1	1.76e-05	102	234	7	C0043094
Disease	developmental and epileptic encephalopathy 87 (implicated_via_orthology)	CDK8 CDK19	6.26e-05	2	234	2	DOID:0112221 (implicated_via_orthology)
Disease	anxiety disorder, stress-related disorder	SDK1 EDIL3 GIGYF2	1.03e-04	12	234	3	EFO_0006788, EFO_0010098
Disease	scoliosis (is_implicated_in)	FBN1 FBN2	3.72e-04	4	234	2	DOID:0060249 (is_implicated_in)
Disease	sensory peripheral neuropathy (implicated_via_orthology)	HARS2 CCT5	3.72e-04	4	234	2	DOID:2491 (implicated_via_orthology)
Disease	Colorectal Carcinoma	CALCOCO2 ACACA OBSCN FBN2 NID1 PMS2 CAD FPGS CUBN ADAMTSL3 KCNH4 PPOX LIFR INTS13 PRPS1	5.27e-04	702	234	15	C0009402
Disease	response to anticonvulsant	SORCS2 NID1 IRF2BPL PRKAR2B WDR41	5.89e-04	85	234	5	GO_0036277
Disease	aspartate aminotransferase measurement	KIF21B PEPD OBSCN DAB2 SRMS CD163 PPARGC1A HMCN2 GCN1 MRC1 ATG7 FKRP CUBN HARS2 WDR41 CTNNA2 CDK6	9.50e-04	904	234	17	EFO_0004736
Disease	severe acute respiratory syndrome, COVID-19	CNTN6 PPARGC1A KSR1 NRXN1 SORCS2 PMS2 MXRA5 EDIL3 MEGF6 WDR41 CDK11B	9.51e-04	447	234	11	EFO_0000694, MONDO_0100096
Disease	Endogenous Hyperinsulinism	CD163 FBN1 MRC1	1.12e-03	26	234	3	C1257963
Disease	Exogenous Hyperinsulinism	CD163 FBN1 MRC1	1.12e-03	26	234	3	C1257964
Disease	Compensatory Hyperinsulinemia	CD163 FBN1 MRC1	1.12e-03	26	234	3	C1257965
Disease	glutathione s-transferase p measurement	NDUFV1 CABP2	1.28e-03	7	234	2	EFO_0020410
Disease	Hyperinsulinism	CD163 FBN1 MRC1	1.39e-03	28	234	3	C0020459
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	ACACA ACADM EZH2 PPARGC1A	1.79e-03	65	234	4	DOID:0080208 (biomarker_via_orthology)
Disease	fatty liver disease (implicated_via_orthology)	ACACA PPARGC1A NFKB1	1.88e-03	31	234	3	DOID:9452 (implicated_via_orthology)
Disease	body fat percentage	PEPD IP6K1 NRXN1 SEMA4D DMXL2 SMCHD1 ADAMTSL3 RIT2 PRMT6 MST1R WDR41	1.91e-03	488	234	11	EFO_0007800
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	NFKB1 NFKB2	2.17e-03	9	234	2	DOID:0050340 (implicated_via_orthology)
Disease	Chloracne	INTS13 CX3CR1 CDK6	2.25e-03	33	234	3	C0263454
Disease	primary dental caries	EGLN3 PDCD6IP CUBN	2.46e-03	34	234	3	EFO_0600095
Disease	ferritin measurement	DHX38 DACT2 STAB1 EGLN3 TENM3	2.64e-03	119	234	5	EFO_0004459
Disease	renal Wilms' tumor (is_implicated_in)	EZH2 TEK	2.70e-03	10	234	2	DOID:5176 (is_implicated_in)
Disease	albumin:globulin ratio measurement	DAB2 MPRIP NFKB1 ARHGAP4	2.73e-03	73	234	4	EFO_0005128
Disease	polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement	PTPRM LOXHD1	3.29e-03	11	234	2	EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964
Disease	Immunoglobulin Deficiency, Late-Onset	NFKB1 NFKB2	3.29e-03	11	234	2	C2936665
Disease	Acquired Hypogammaglobulinemia	NFKB1 NFKB2	3.29e-03	11	234	2	C2936664
Disease	heel bone mineral density, urate measurement	SORCS2 ATG7 INTS13 WDR41 CTNNA2 ARHGAP18	3.41e-03	182	234	6	EFO_0004531, EFO_0009270
Disease	prediabetes syndrome (biomarker_via_orthology)	PPARGC1A RELB	3.92e-03	12	234	2	DOID:11716 (biomarker_via_orthology)
Disease	retinitis pigmentosa (is_implicated_in)	SAG FSCN2 PRPS1	4.20e-03	41	234	3	DOID:10584 (is_implicated_in)
Disease	Common variable immunodeficiency	NFKB1 NFKB2	4.61e-03	13	234	2	cv:C0009447
Disease	cognitive function measurement	EFCAB5 IP6K1 STAB1 CAPN8 JAK1 NRXN1 VWC2L SDK1 PMS2P3 SEMA4D DMXL2 ADAMTSL3 RIT2 MST1R GUCA1A CPEB4 GIGYF2 CTNNA2 AJUBA HYDIN MYBPC2	5.25e-03	1434	234	21	EFO_0008354
Disease	ascending aortic diameter	RERG FBN1 FBN2 HMCN1 HYDIN	5.27e-03	140	234	5	EFO_0021787
Disease	neuroimaging measurement	KIF21B EFTUD2 JAK1 PPARGC1A NEO1 FBN2 MRC1 SEMA4D PDPR FZD3 RDH14 DPYSL4 RIT2 COL18A1 CPEB4 ARHGAP18 CDK6	5.33e-03	1069	234	17	EFO_0004346
Disease	inositol measurement	MYO10 RIT2	5.35e-03	14	234	2	EFO_0010504
Disease	trimethylamine-N-oxide measurement	CUBN INTS13	5.35e-03	14	234	2	EFO_0010541
Disease	Autosomal recessive limb-girdle muscular dystrophy	FKRP TRIM32	5.35e-03	14	234	2	cv:C2931907
Disease	carbohydrate measurement	PTPRM GRIA1 TEK	5.81e-03	46	234	3	EFO_0004998
Disease	pancreatic adenocarcinoma (is_implicated_in)	JAK1 CDK6	6.14e-03	15	234	2	DOID:4074 (is_implicated_in)
Disease	Common Variable Immunodeficiency	NFKB1 NFKB2	6.14e-03	15	234	2	C0009447
Disease	glycerate measurement	HMCN1 AGRN	6.14e-03	15	234	2	EFO_0021029
Disease	frontal fibrosing alopecia	EFCAB5 MYO10 SDK1	6.55e-03	48	234	3	EFO_0009855
Disease	central nervous system disease (implicated_via_orthology)	IRF2BPL GRIA1	6.98e-03	16	234	2	DOID:331 (implicated_via_orthology)
Disease	Liver carcinoma	CYLD ACACA HJURP EZH2 CD163 VIPR1 DCAF4L2 ATG7 LIFR IGF2R	7.58e-03	507	234	10	C2239176
Disease	sitting height ratio	JAK1 PTPRM ADAMTSL3	7.75e-03	51	234	3	EFO_0007118
Disease	hearing impairment	CDK8 TMPRSS3 LOXHD1 PRPS1	7.79e-03	98	234	4	C1384666
Disease	pulse pressure measurement	POP7 PEPD CHRM2 NEK9 SVEP1 PPARGC1A FBN1 FBN2 CCN3 MXRA5 PDPR ATG7 ADAMTSL3 KCNH4 GALNT9 LPP CTNNA2 CDK11B HYDIN CDK6	7.81e-03	1392	234	20	EFO_0005763
Disease	cortical thickness	STAB1 NEO1 FBN1 FBN2 NFKB1 SEMA4D EGLN3 FZD3 RDH14 DPYSL4 ADAMTSL3 RAB44 RIT2 COL18A1 TSPAN10 CPEB4 ARHGAP18	7.83e-03	1113	234	17	EFO_0004840
Disease	muscular dystrophy (is_implicated_in)	FKRP TRIM32	7.87e-03	17	234	2	DOID:9884 (is_implicated_in)
Disease	low density lipoprotein cholesterol measurement, body fat percentage	EVI5 UGT1A8	7.87e-03	17	234	2	EFO_0004611, EFO_0007800
Disease	respiratory symptom change measurement, response to placebo	CNTN6 PPARGC1A	7.87e-03	17	234	2	EFO_0008344, EFO_0010068
Disease	C-reactive protein measurement	JAK1 NEO1 NFKB1 PVR NID1 GCN1 CCN3 SEMA6C PMS2P3 SEMA4D DMXL2 CAD GRIA1 RELB RIT2 MST1R RAVER2 BCAM	7.89e-03	1206	234	18	EFO_0004458

Protein segments in the cluster

Peptide	Gene	Start	Entry
CQVGIFLDYEAGDVS	BTN2A3P	416	Q96KV6
HCGVDGYVDNIEDLR	EDDM3A	126	Q14507
RAEAEDGLLLYCGEN	EGFLAM	416	Q63HQ2
VEDLFEYEGCKVGRG	CDK19	16	Q9BWU1
GYGDCAVGARYQDEL	AJUBA	266	Q96IF1
RCIGYGDENDVFRSN	FCRL4	166	Q96PJ5
LVICCEGNAGFYEVG	ABHD16A	281	O95870
AYGTGFVGCLRDVVV	AGRN	2031	O00468
IVEDGGHVFAGQCYA	ACACA	766	Q13085
DLAEACYIGDIVVFG	CX3CR1	16	P49238
VGVRTVEDGECYIQF	CHRM2	166	P08172
QQYECVAEIGEGAYG	CDK6	11	Q00534
LLDAGVEVNATDCYG	ANKRD22	121	Q5VYY1
TCAFRYGQEDIDVIG	SAG	66	P10523
ADRIGIGCSLVRGEY	ARMC3	806	Q5W041
CYEALAGGSTVEGFE	CAPN8	191	A6NHC0
EEFQCLNRIEEGTYG	CDK11B	436	P21127
YGSGCDIVILANDFE	DMXL2	31	Q8TDJ6
ELAYGCTGVQTAIEG	ACADM	111	P11310
NVGYTQDVRGECIDV	FBN3	436	Q75N90
SGGDRVCFNLGRELY	DMWD	121	Q09019
YASGCDIVILGSDFE	DMXL1	31	Q9Y485
VGFCYLDNFLGEVVG	EGLN3	26	Q9H6Z9
EGEAVHLARDFGYVC	TFAP2E	301	Q6VUC0
TEEFCVGKSELRGYG	AP4M1	231	O00189
EGDGIIRELCISYGG	AOX1	451	Q06278
AEYFECAGNRAGRDV	HJURP	161	Q8NCD3
ARGEIIYSLDGSDCV	NWD2	1326	Q9ULI1
YICFRNGEEEDENGA	NWD2	1581	Q9ULI1
REVEGLEASGSVYIC	RAG1	716	P15918
GNIERCFLVYSEVTG	RAVER2	166	Q9HCJ3
GEETQRYCTDTGVLF	PEPD	51	P12955
QELGVYFGECSAALG	RAB44	966	Q7Z6P3
DDCTVGYIVEGLLGA	RFNG	236	Q9Y644
RYECEGRSAGSILGE	RELB	141	Q01201
GSGEYTAEELCIRAA	JAK1	51	P23458
CGGRVTDYRITDFGE	INTS13	406	Q9NVM9
AGACEAAARVYDLGL	NRTN	131	Q99748
RDVTDNRAFGYVCGG	DAB2	126	P98082
EELGYNCQTGGVIAE	NOP56	106	O00567
YGGSDCALARLELQE	DOK2	31	O60496
FEAGRRCVSGEGNFE	DOK2	211	O60496
EIETYCRLIDGDGNS	KRT28	386	Q7Z3Y7
EGYVLQATCERGFAA	MPRIP	716	Q6WCQ1
DEGDYECVAQNRFGL	IGDCC3	111	Q8IVU1
GGIYVVCVVAANEAG	LRRN4CL	146	Q8ND94
CSAEITADYGDGRGE	MAGEE2	11	Q8TD90
CGEYGRLGLDSEEDY	NEK9	506	Q8TD19
GAEGILTRECADQYG	NRAP	281	Q86VF7
GCSFVVDREYFGDIG	GALNT9	326	Q9HCQ5
YCLDQGAEDGDRAIL	GALNT9	476	Q9HCQ5
VGDEGRYQCVAFSPA	HMCN2	1501	Q8NDA2
GQDRCADVTLEGQVY	MESD	176	Q14696
EIRVYALSGDQGGCS	IL12RB2	496	Q99665
ANVYLCLFGDVGDTG	LOXHD1	571	Q8IVV2
CLFGDVGDTGERLLY	LOXHD1	576	Q8IVV2
EGVVAAVGQDCYTRI	DCAF4L2	326	Q8NA75
YCGEIISQDEADRRG	EZH2	641	Q15910
RGCVNYEGADRIEFV	IRF2BPL	36	Q9H1B7
SGGEEQAQYCRAAEE	PDCD6IP	31	Q8WUM4
ARAVGDGILCNTYID	PDCD4	266	Q53EL6
VEFPIGCEQAGVEYR	PLXNA1	296	Q9UIW2
GCEQAGVEYRLVQDA	PLXNA1	301	Q9UIW2
GGIERENGCLVYNDT	PLXNA1	1086	Q9UIW2
VYVIADGNEEGCFDI	FAT2	751	Q9NYQ8
GASGDECGRLQYALT	KSR1	151	Q8IVT5
LNEGGGYENDCSIAR	PDPR	566	Q8NCN5
CDVGYNFLIGEDGLV	PGLYRP1	91	O75594
CDVAYNFLVGDDGRV	PGLYRP3	81	Q96LB9
GYQFSDEGTCVAVVD	NID1	741	P14543
GGFVALYVDCEEFQR	COL18A1	586	P39060
LVDREVGYCQGSAFI	EVI5	236	O60447
DGREVLGGANDGCLY	DCAF11	276	Q8TEB1
LGGANDGCLYVFDRE	DCAF11	281	Q8TEB1
LIEGCFEGYNATVLA	KIF21B	71	O75037
RAGYVGCVRDLFIDG	NRXN2	651	Q9P2S2
GCDEVYYLGEGEASR	HEXD	146	Q8WVB3
SCAEGIVVFRTDYGQ	MYO10	26	Q9HD67
YGVDLIEVSDNGCGV	PMS2P3	136	Q13401
SDGFCELTGYGRTEV	KCNH4	46	Q9UQ05
GSDELFVGRAGYLCA	LANCL3	166	Q6ZV70
EYFGRCARCGENVVG	LPP	411	Q93052
QLCGGDGRLGVYEVS	KREMEN2	201	Q8NCW0
DGRLGVYEVSVGSCQ	KREMEN2	206	Q8NCW0
LCFGDGNQYVREAAD	GCN1	1466	Q92616
GGQALRDAGYEFDIC	PGAM4	41	Q8N0Y7
GDIDYCELNARFGFR	NRXN1	886	Q9ULB1
CSDNRIDVIYGFFGA	OR51A2	191	Q8NGJ7
CSDNRIDVIYGFFGA	OR51A4	191	Q8NGJ6
QAGDRYVVADCGGGT	HSPA12B	311	Q96MM6
YRIFGETIDIAVGNC	OSGEP	146	Q9NPF4
DGDGCRELVVGYTDR	ITFG2	136	Q969R8
DAGDYTCVAINEAGR	HMCN1	766	Q96RW7
DRGQYICVATSVAGE	HMCN1	1706	Q96RW7
DAGQYTCVVRNAAGE	HMCN1	2451	Q96RW7
GRYTCVASNIAGEDE	HMCN1	2741	Q96RW7
EDAGRYTCVAVNEAG	HMCN1	2841	Q96RW7
TDIGRYVCVAENTAG	HMCN1	2936	Q96RW7
DDAGLYECVSRGGRI	OBSCN	771	Q5VST9
AGEYSCEAGGQRVSF	OBSCN	1141	Q5VST9
ADAGEYSCEAGGQRV	OBSCN	1231	Q5VST9
TVLGLRAEDAGEYVC	OBSCN	1866	Q5VST9
ELQICGLAVADAGEY	OBSCN	3416	Q5VST9
IRGLAVVDAGEYSCV	OBSCN	3771	Q5VST9
LVRGVEQEDAGDYTC	OBSCN	4036	Q5VST9
CTVNLRDDGDSYGFI	PPARGC1A	706	Q9UBK2
LDGGARGQNACSEIY	POP7	56	O75817
AVYQVACGDELTGEG	CUBN	811	O60494
DNISGVCFVGLYDLD	FZD6	351	O60353
YNIFEGVECRGAPAV	DPYSL4	431	O14531
VQVACYEILGEFSGE	EFCAB5	1291	A4FU69
GGTCEISEAYRGDTF	EDIL3	86	O43854
LSGFELYGTVNGVCE	HECTD1	1231	Q9ULT8
VGCEYQPRGDTVEGL	HYI	246	Q5T013
EISDIQRGQAGEYEC	IGLON5	181	A6NGN9
DCYRGVVFDGLDTLF	HYDIN	2226	Q4G0P3
SLGPEDEGAYRCVVA	CD101	366	Q93033
REGAGLVVASGVIYC	KLHL12	416	Q53G59
VRQPLYEFEDCLGGG	ATG7	396	O95352
GGAQSRDCDLALGYV	DACT2	706	Q5SW24
DRLYGGVCYAGIDTD	CPEB2	461	Q7Z5Q1
YEVDCDVIDGGRASQ	CTNNA2	821	P26232
GECGFYQRSFDEVEG	GIGYF2	131	Q6Y7W6
EGDNCVFDGVIYRSG	CCN3	106	P48745
FLEQCVYDLCVVGGE	FCGBP	696	Q9Y6R7
ECEIGYELDRSGGNC	FBN1	1471	P35555
AGCTFQDIILEARYG	DMBX1	51	Q8NFW5
AEERGAVLGHEVGYC	DHX35	121	Q9H5Z1
AVLGHEVGYCIRFDD	DHX35	126	Q9H5Z1
VYGCADGERTQATER	COBL	651	O75128
RGAVYADSGNFERCI	FEM1A	396	Q9BSK4
GGDEFCRRYQDQLEA	ATL2	436	Q8NHH9
DDSSCEVNGRLYREG	CCN5	96	O76076
QFCYVDEDGVVRGAS	CALCOCO2	106	Q13137
ELEAGVGGRFRCSCY	PRMT6	266	Q96LA8
DEGFYECIASNLRGR	CNTN6	291	Q9UQ52
SLCRVGVFLDYEAGD	BTN2A1	446	Q7KYR7
FKLYDVDGNGCIDRD	GUCA1A	96	P43080
NISGVCFVGLYDVDA	FZD3	356	Q9NPG1
VVSVCFEGDSDGYIN	IP6K1	76	Q92551
LAVVEVGIGGAYDCT	FPGS	196	Q05932
RGTFDIYVKCDGVGR	PRKAR2B	196	P31323
DRLYGGVCYAGIDTD	CPEB4	601	Q17RY0
ICDDGYELDRTGGNC	FBN2	1516	P35556
GIYLEDVGNCEQLRG	FKRP	366	Q9H9S5
TRCGYTGEDGVEISV	AMT	221	P48728
ERCNSLAFGGYLSEV	CYLD	556	Q9NQC7
CVVYGGADIGQQIRD	DDX3Y	296	O15523
SGFGEDVDGYCDTIV	EXOC3	646	O60645
GNDRYEGYCVELAAE	GRIA1	431	P42261
ESLCRVGVFLDYEAG	BTN2A2	441	Q8WVV5
QVGDERDYVCVVRAG	BCAM	116	P50895
SREACAGRLEVFYNG	CD163	831	Q86VB7
VEDLFEYEGCKVGRG	CDK8	16	P49336
EVYAGDICALFGIDC	GFM1	411	Q96RP9
DIGDYSCEIVSEGGN	SDK1	641	Q7Z5N4
GYLQCFDLEGESGLV	C2CD5	221	Q86YS7
AFQEFDRDRDGYIGC	CABP2	86	Q9NPB3
SVCVYGGGNRDEQIE	DDX43	346	Q9NXZ2
GGQALRDAGYEFDIC	PGAM1	41	P18669
SGTGRGTDYEVCIEN	LIFR	71	P42702
DGACLFRAVADQVYG	OTUD5	221	Q96G74
VVICYFGEGAASEGD	BCKDHA	231	P12694
EEYNGGEGRTVVHCL	PTPRM	1376	P28827
RGGEFQCGLEAASVY	RNF180	306	Q86T96
GDRQGLLGAYHDEAC	NXF2	406	Q9GZY0
SYEDADCVVIIGGAS	MRC1	1046	P22897
GRYLSAEEDGRVACE	FSCN2	66	O14926
GFRGERCQAECELGY	MEGF6	676	O75095
RGFEGFCLVGVSDLD	FBXL16	166	Q8N461
VLRTSGEGGCFYEFE	IGF2R	596	P11717
FGLRVEDEGNYTCLF	PVR	111	P15151
LDFYEGQGRLDGALC	UPP1	211	Q16831
ANCFEALIGAVYLEG	DROSHA	1041	Q9NRR4
DDGGYRITDDGADCL	TRMT13	401	Q9NUP7
CDAEGTVYFTQGLGL	TRIM32	521	Q13049
VDGEDNTVGCRLGKY	TRMT2A	251	Q8IZ69
DRIGDYVQCHGGVSL	HARS2	266	P49590
QVGERSDYAGFRACV	SMCHD1	46	A6NHR9
FADGCVLRADVGIYA	PRSS58	211	Q8IYP2
GDQLCGQSSVEGYIR	PLCD4	311	Q9BRC7
LRCIQSEVSFEGAYG	SMG5	236	Q9UPR3
GEGTVAAGYQDFIIC	TMEM184B	286	Q9Y519
GGEGFIICYSVTDRQ	RIT2	91	Q99578
FVVRGAGAYICGEET	NDUFV1	196	P49821
GQTIYLRGTGDFDLC	ENTPD4	381	Q9Y227
GAGCISEGRAYDTDA	FN3K	21	Q9H479
ATEGDGGLYRCVVES	NEO1	211	Q92859
EAQDLGGDFRYVTCA	SORCS2	311	Q96PQ0
CVGEAGDTVQFAEYI	PSMB2	46	P49721
CEYAGEVLGFSEVQR	SETMAR	166	Q53H47
CDEVNVYGFGADSRG	ST3GAL2	291	Q16842
NRVVYGGGAAEISCA	CCT5	416	P48643
SGCGEYTRVFREQGI	SAMD11	556	Q96NU1
GGRVVADLSCVGDEY	MTG2	166	Q9H4K7
ADLSCVGDEYIAALG	MTG2	171	Q9H4K7
GLQGYVLELCREGAS	MYBPH	101	Q13203
RLAYTDDLGAVGGAC	WIPI2	416	Q9Y4P8
EGVSGRYFGDCKEEE	RDH14	296	Q9HBH5
VRYLCEGAGDGEEEA	RFXAP	71	O00287
EDTGLCTEGLYRVSG	ARHGAP5	1286	Q13017
FDVGCEQHGEYRLTD	RSPH1	176	Q8WYR4
EGDSGVYQCLSEERV	SEMA4D	616	Q92854
DRLCALEEGGGYIFA	SRMS	76	Q9H3Y6
ESVRGEDVYIVQSGC	PRPS1L1	46	P21108
ESCRIGSYQDEEGQL	SVEP1	1016	Q4LDE5
EYTCNEGFLLEGARS	SVEP1	2856	Q4LDE5
VIEYGTVNGTDFDCG	SVEP1	3011	Q4LDE5
CDEGAGISGDYIDRV	OS9	196	Q13438
EGVVEAVACFAYTGR	ARHGAP4	746	P98171
DCRGLLENEGTVYED	SMURF1	151	Q9HCE7
LVLEYAAGGEIFDQC	STK17A	136	Q9UEE5
TGEGNITEIFYELCR	RERG	151	Q96A58
DIREFYGQTETGLTC	ACSM2B	356	Q68CK6
EEFIGAGEQARYCHG	CHPF2	211	Q9P2E5
GEDEYRCVRVGGQNA	TMPRSS3	101	P57727
LAGASYEGVAVNDCI	PPOX	446	P50336
YEGVAVNDCIESGRQ	PPOX	451	P50336
GQFYEAESCLVEAGR	URGCP	621	Q8TCY9
VDYRNTLGLCGTFDE	VWDE	556	Q8N2E2
AGGQAARLQEECDYV	VIPR1	26	P32241
GFFAYTCGRLVVVED	WDR90	1131	Q96KV7
DEGLYECRVTDANYG	VSTM2A	121	Q8TAG5
CEGLGAAAARLGQYD	TTC24	356	A2A3L6
ESLNEVGYDDIGGCR	VCP	196	P55072
TRGLVGQLFCDFGED	UBA7	151	P41226
EDCALRGSRYDGQIA	UBA7	406	P41226
AIECYTRGIAADGAN	RPAP3	301	Q9H6T3
LEEYGAGVCSTRQEI	SPTLC2	196	O15270
LGGRNFDEALVDYFC	HSPA4L	231	O95757
GDYDLQVGIVEALCR	SYCP2	211	Q9BX26
ESVRGEDVYIIQSGC	PRPS2	46	P11908
EELRDCLVAAAPYGG	VPS16	31	Q9H269
VCAFYLDEIERGFEG	SEMA6C	331	Q9H3T2
ESEVGDGRACYGHLL	STAB1	346	Q9NY15
VALACGIDGSLYVGD	TENM3	1176	Q9P273
GEEVGYAIRFEDCTS	DHX38	606	Q92620
INGAYFCEGRVRGEA	TEK	96	Q02763
PDNYEAGRAEACGTL	RALGAPB	506	Q86X10
LYEIGGNIGERCLDD	ARHGAP18	626	Q8N392
GEVAGFGESRCEAYL	CAD	1286	P27708
YGVDLIEVSDNGCGV	PMS2	61	P54278
GFCYQEVAGPREALA	ZNF446	31	Q9NWS9
DADAAQRVVYLEGCG	TSPAN10	266	Q9H1Z9
ARGCDGAARGFETYE	WFIKKN1	331	Q96NZ8
GAARGFETYEACQQA	WFIKKN1	336	Q96NZ8
DNLIFDDYRGKGCVD	VWC2L	41	B2RUY7
FAQREHCELELGGGY	ZNF544	151	Q6NX49
DVECGGGFYIRSLVS	TRUB1	246	Q8WWH5
ESVRGEDVYIVQSGC	PRPS1	46	P60891
QEGGDTDLRSYGCFV	ZNF295-AS1	111	Q8N0V1
ERANPEGLCYGLFGD	WDR24	336	Q96S15
YVCGECGRGFIVESV	ZNF589	276	Q86UQ0
CYTDILFTEQERGVG	EFTUD2	166	Q15029
KFEYIGLGAVADCVG	MST1R	881	Q04912
GGLEAGAVYICTEDA	XRCC3	131	O43542
CGEDRAFIGNAYIAV	USP6	981	P35125
CDEENVFAAVGRGLY	WDR41	291	Q9HAD4
IDCGEDRAFIGNAYI	USP32	1181	Q8NFA0
EELYVDRVCGQGLGQ	ZNF169	511	Q14929
VVFARGIACHYLEEG	UGT1A8	166	Q9HAW9
GGGYQLNSAECVDIR	ADAMTSL3	356	P82987
DIGVYRCIAGSAQET	ADAMTSL3	976	P82987
AGDYLCVARNKVGDD	MXRA5	2216	Q9NR99
GTYTCRAVNELGEAL	MYBPC2	1116	Q14324
CGYLDIAEFLIGQGA	PPP1R12A	116	O14974
DRTAGCVTGGEEIYL	NFKB1	256	P19838
TAGSVRGGDEVYLLC	NFKB2	236	Q00653